A Clinico-Pathological Analysis of Seventeen Cases of Non-Hodgkin'S Lymphoma Involving the Orbit

References

• Anderson T, Harris G, Hanson G, et al. Orbital lymphoma, problems in diagnosis of lymphoproliferative diseases. Proc Am Soc Clin Oncol 1987; 6: 798
   Google Scholar
• Austin-Seymour M M, Donaldson S S, Egbert P R, Mc-Doughall I R, Kriss JP. Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys 1985; 11: 371–9
   PubMed Web of Science ®Google Scholar
• Barthold H J, Harvey A, Markoe A M, Brady L W, Augs-Burger J J, Shields JA. Treatment of orbital psudotumours and lymphoma. Am J Clin Oncol 1986; 9: 527–32
   PubMedGoogle Scholar
• Bennett C L, Putterman A, Bitran J D, et al. Staging and therapy of orbital lymphomas. Cancer 1986; 57: 1204–8
   PubMedGoogle Scholar
• Bessel E M, Henk J M, Wright J E, Whitelocke RA. Orbital and conjunctival lymphoma, treatment and prognosis. Radiother Oncol 1988; 13: 237–44
   PubMedGoogle Scholar
• Ellis J H, Banks P M, Campbell R J, Liesegang TJ. Lymphoid tumours of the ocular adnex, clinical correlation with the Working Formulation Classification and immunoperoxidase staining of paraffin sections. Ophthalmology 1985; 92: 1311–24
   PubMed Web of Science ®Google Scholar
• Gordon P S, Juillard G J, Selch M T, Parker R G, Fu YS. Orbital lymphomas and pseudolymphomas, treatment with radiation therapy. Radiology 1986; 159: 797–9
   PubMed Web of Science ®Google Scholar
• Jereb B, Lee H, Jakobiec F A, Kutcher J. Radiation therapy of conjunctival and orbital lymphoid tumours. Int J Radiat Oncol Biol Phys 1984; 10: 1013–9
   PubMed Web of Science ®Google Scholar
• Lauer S A, Fischer J, Jones J, Gartner S, Ducher J, Hoxie JA. Orbital T-cell lymphoma in human T-cell leukaemia virus I infection. Ophthalmology 1988; 95: 110–5
   PubMed Web of Science ®Google Scholar
• Lazzarino M, Morra E, Rossa R, et al. Clinicopathologic and immunologic characteristics of non-Hodgkin's lymphomas presenting in the orbit. Cancer 1985; 55: 1907–12
   PubMed Web of Science ®Google Scholar
• Makepeace A R, Fermont D C, Bennett MH. Primary non-Hodgkin's lymphoma of the orbit. J R Soc Med 1988; 81: 640–2
   PubMedGoogle Scholar
• Medeiros L J, Harmon D C, Linggood R M, Harris NL. Immunohistologic features predict clinical behavior of orbital and conjunctival lymphoid infiltrates. Blood 1989; 74: 2121–9
   PubMed Web of Science ®Google Scholar
• Neri A, Jakobiec F A, Pelicci P G, Dalla-Favera R, Knowles DM., II. Immunoglobulin and T-cell receptor beta gene rearrangement analysis of ocular adnexal lymphoid neoplasms: clinical and biologic implications. Blood 1987; 70: 1519–29
   PubMed Web of Science ®Google Scholar
• Reddy E K, Bhatia P, Evans RG. Primary orbital lymphomas. Int J Radiat Oncol Biol Phys 1988; 15: 1239–41
   PubMedGoogle Scholar
• The Non-Hodgkin's Lymphoma Pathologic Classification Project. NCI sponsored study of classifications of non-Hodgkin's lymphomas. Cancer 1982; 49: 2112–35
   PubMed Web of Science ®Google Scholar
• Ho F CS, Loke S L, Hui P K, Todd D. Immunohistological subtypes of non-Hodgkin's lymphoma in Hong Kong Chi-neses. Pathology 1986; 18: 426–30
   PubMed Web of Science ®Google Scholar
• Carbone P P, Kaplan H S, Mushoff K, Smithiers D W, Tubiana M. Report of the Committee on Hodgkin's Disease staging. Cancer Res 1971; 31: 1860–1
   PubMed Web of Science ®Google Scholar
• Anderson T, Bender R A, Fisher R I, et al. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term follow-up. Cancer Treat Rep 1977; 61: 1057–66
   PubMedGoogle Scholar
• De Vita V T, Serpick A A, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970; 73: 881–95
   PubMed Web of Science ®Google Scholar
• McKelvey E M, Gottlieb J A, Wilson H E, et al. Hydroxyl-daunorubicin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 1976; 38: 1484–93
   PubMed Web of Science ®Google Scholar
• Schein P S, De Vita VT, Jr, Hubbard S, et al. Bleomycin, adriamycin, cyclophosphamide, vincristine, prednisone (BACOP) combination chemotherapy in the treatment of advanced aggressive histiocytic lymphoma. Ann Intern Med 1976; 85: 417–22
   PubMed Web of Science ®Google Scholar
• Shipp M A, Harrington D P, Klatt M M, et al. Identification of major prognostic subgroups of patients with large cell lymphoma treated with m-BACOD or M-BACOD. Ann Intern Med 1986; 104: 757–65
   PubMed Web of Science ®Google Scholar
• Liang R, Chiu E KW, Chan T K, Todd D, Loke SL. Management of advanced stage intermediate grade non-Hodgkin's lymphomas. Hematol Oncol 1990; 8: 147–54
   PubMedGoogle Scholar
• Ho F CS, Choy D, Loke S L, et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract, a clinico-pathological study of 70 cases, and immunophe-notypic studies on 16 cases. Hum Pathol 1990; 21: 1041–50
   PubMed Web of Science ®Google Scholar
• Liang R, Todd D, Chan T K, et al. Nasal lymphoma: a retrospective analysis of 60 cases. Cancer 1990; 66: 1850–5
   PubMed Web of Science ®Google Scholar